220 related articles for article (PubMed ID: 29559451)
1. Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes.
Bingley PJ; Wherrett DK; Shultz A; Rafkin LE; Atkinson MA; Greenbaum CJ
Diabetes Care; 2018 Apr; 41(4):653-661. PubMed ID: 29559451
[TBL] [Abstract][Full Text] [Related]
2. Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience.
Greenbaum CJ; Speake C; Krischer J; Buckner J; Gottlieb PA; Schatz DA; Herold KC; Atkinson MA
Diabetes; 2018 Jul; 67(7):1216-1225. PubMed ID: 29769238
[TBL] [Abstract][Full Text] [Related]
3. Type 1 Diabetes TrialNet--an international collaborative clinical trials network.
Skyler JS; Greenbaum CJ; Lachin JM; Leschek E; Rafkin-Mervis L; Savage P; Spain L;
Ann N Y Acad Sci; 2008 Dec; 1150():14-24. PubMed ID: 19120262
[TBL] [Abstract][Full Text] [Related]
4. Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going?
Lord S; Greenbaum CJ
Pharmacol Res; 2015 Aug; 98():3-8. PubMed ID: 25771310
[TBL] [Abstract][Full Text] [Related]
5. Insulin is necessary but not sufficient: changing the therapeutic paradigm in type 1 diabetes.
Lord S; Greenbaum CJ
F1000Res; 2020; 9():. PubMed ID: 32789003
[TBL] [Abstract][Full Text] [Related]
6. Emerging Concepts on Disease-Modifying Therapies in Type 1 Diabetes.
Greenbaum C; Lord S; VanBuecken D
Curr Diab Rep; 2017 Oct; 17(11):119. PubMed ID: 29039056
[TBL] [Abstract][Full Text] [Related]
7. Understanding and preventing type 1 diabetes through the unique working model of TrialNet.
Battaglia M; Anderson MS; Buckner JH; Geyer SM; Gottlieb PA; Kay TWH; Lernmark Å; Muller S; Pugliese A; Roep BO; Greenbaum CJ; Peakman M
Diabetologia; 2017 Nov; 60(11):2139-2147. PubMed ID: 28770323
[TBL] [Abstract][Full Text] [Related]
8. Prevention strategies for type 1 diabetes.
Kishiyama CM; Chase HP; Barker JM
Rev Endocr Metab Disord; 2006 Sep; 7(3):215-24. PubMed ID: 17180706
[TBL] [Abstract][Full Text] [Related]
9. The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.
Mahon JL; Sosenko JM; Rafkin-Mervis L; Krause-Steinrauf H; Lachin JM; Thompson C; Bingley PJ; Bonifacio E; Palmer JP; Eisenbarth GS; Wolfsdorf J; Skyler JS; ;
Pediatr Diabetes; 2009 Apr; 10(2):97-104. PubMed ID: 18823409
[TBL] [Abstract][Full Text] [Related]
10. Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials.
Senior PA; Pettus JH
Diabet Med; 2019 Mar; 36(3):297-307. PubMed ID: 30362170
[TBL] [Abstract][Full Text] [Related]
11. The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention.
Pozzilli P
Diabetes Metab Res Rev; 2002; 18(4):257-9. PubMed ID: 12203941
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study.
Sosenko JM; Skyler JS; Mahon J; Krischer JP; Beam CA; Boulware DC; Greenbaum CJ; Rafkin LE; Cowie C; Cuthbertson D; Palmer JP;
Diabetes Care; 2011 Aug; 34(8):1785-7. PubMed ID: 21680724
[TBL] [Abstract][Full Text] [Related]
13. A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies.
Deverka PA; Bangs R; Kreizenbeck K; Delaney DM; Hershman DL; Blanke CD; Ramsey SD
J Natl Cancer Inst; 2018 Jun; 110(6):553-559. PubMed ID: 29684151
[TBL] [Abstract][Full Text] [Related]
14. Challenges to Reshape the Future of Type 1 Diabetes Research.
Bleich D; Wagner DH
J Clin Endocrinol Metab; 2018 Aug; 103(8):2838-2842. PubMed ID: 29912401
[TBL] [Abstract][Full Text] [Related]
15. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
16. Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective.
Sims EK; Besser REJ; Dayan C; Geno Rasmussen C; Greenbaum C; Griffin KJ; Hagopian W; Knip M; Long AE; Martin F; Mathieu C; Rewers M; Steck AK; Wentworth JM; Rich SS; Kordonouri O; Ziegler AG; Herold KC;
Diabetes; 2022 Apr; 71(4):610-623. PubMed ID: 35316839
[TBL] [Abstract][Full Text] [Related]
17. UCSD health sciences receives $10M for Clinical & Translational Research Institute.
J Investig Med; 2011 Jun; 59(5):743. PubMed ID: 22121526
[No Abstract] [Full Text] [Related]
18. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus.
Libby P; Nathan DM; Abraham K; Brunzell JD; Fradkin JE; Haffner SM; Hsueh W; Rewers M; Roberts BT; Savage PJ; Skarlatos S; Wassef M; Rabadan-Diehl C; ;
Circulation; 2005 Jun; 111(25):3489-93. PubMed ID: 15983263
[No Abstract] [Full Text] [Related]
19. A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.
Sosenko JM; Skyler JS; DiMeglio LA; Beam CA; Krischer JP; Greenbaum CJ; Boulware D; Rafkin LE; Matheson D; Herold KC; Mahon J; Palmer JP; ;
Diabetes Care; 2015 Feb; 38(2):271-6. PubMed ID: 25519451
[TBL] [Abstract][Full Text] [Related]
20. Maternal immunization efforts of the National Institutes of Health.
Rubin FA; Koso-Thomas M; Isaacs MB; Piper J; Read J; Nesin M
Vaccine; 2015 Nov; 33(47):6380-7. PubMed ID: 26458798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
